TP53 and cancer: Overexpression of HERV-K (HML-2) env, on the other hand, increased breast cancer cell transformation, migration, and invasion, as well as restored the cancer-related signaling pathways mentioned above alongside the downregulation of p53 (HGNC: TP53) [75].